vs
ASTEC INDUSTRIES INC(ASTE)与Revvity(RVTY)财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是ASTEC INDUSTRIES INC的1.9倍($772.1M vs $400.6M),Revvity净利率更高(12.7% vs 3.0%,领先9.7%),ASTEC INDUSTRIES INC同比增速更快(11.6% vs 5.9%),Revvity自由现金流更多($161.8M vs $7.4M),过去两年ASTEC INDUSTRIES INC的营收复合增速更高(13.8% vs 9.0%)
ASTEC是一家国际电子企业,原总部设于香港,主营电源供应装置与电力转换硬件产品,是全球计算机系统电源的主要供应商之一,曾一度是全球规模最大的电源生产商。
Revvity是一家美国生命科学与诊断领域企业,主要服务制药、生物技术行业客户,重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案,其前身为业务布局多元的老牌企业珀金埃尔默。
ASTE vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.9倍
$400.6M
营收增速更快
ASTE
高出5.7%
5.9%
净利率更高
RVTY
高出9.7%
3.0%
自由现金流更多
RVTY
多$154.4M
$7.4M
两年增速更快
ASTE
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $400.6M | $772.1M |
| 净利润 | $12.0M | $98.4M |
| 毛利率 | 27.3% | — |
| 营业利润率 | 5.7% | 14.5% |
| 净利率 | 3.0% | 12.7% |
| 营收同比 | 11.6% | 5.9% |
| 净利润同比 | -43.1% | 3.9% |
| 每股收益(稀释后) | $0.52 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTE
RVTY
| Q4 25 | $400.6M | $772.1M | ||
| Q3 25 | $350.1M | $698.9M | ||
| Q2 25 | $330.3M | $720.3M | ||
| Q1 25 | $329.4M | $664.8M | ||
| Q4 24 | $359.0M | $729.4M | ||
| Q3 24 | $291.4M | $684.0M | ||
| Q2 24 | $345.5M | $691.7M | ||
| Q1 24 | $309.2M | $649.9M |
净利润
ASTE
RVTY
| Q4 25 | $12.0M | $98.4M | ||
| Q3 25 | $-4.2M | $46.7M | ||
| Q2 25 | $16.7M | $53.9M | ||
| Q1 25 | $14.3M | $42.2M | ||
| Q4 24 | $21.1M | $94.6M | ||
| Q3 24 | $-6.2M | $94.4M | ||
| Q2 24 | $-14.0M | $55.4M | ||
| Q1 24 | $3.4M | $26.0M |
毛利率
ASTE
RVTY
| Q4 25 | 27.3% | — | ||
| Q3 25 | 24.1% | 53.6% | ||
| Q2 25 | 26.7% | 54.5% | ||
| Q1 25 | 28.1% | 56.5% | ||
| Q4 24 | 28.7% | — | ||
| Q3 24 | 22.9% | 56.3% | ||
| Q2 24 | 23.5% | 55.7% | ||
| Q1 24 | 24.9% | 54.6% |
营业利润率
ASTE
RVTY
| Q4 25 | 5.7% | 14.5% | ||
| Q3 25 | 0.3% | 11.7% | ||
| Q2 25 | 6.5% | 12.6% | ||
| Q1 25 | 6.2% | 10.9% | ||
| Q4 24 | 9.7% | 16.3% | ||
| Q3 24 | -2.5% | 14.3% | ||
| Q2 24 | -3.1% | 12.4% | ||
| Q1 24 | 2.0% | 6.8% |
净利率
ASTE
RVTY
| Q4 25 | 3.0% | 12.7% | ||
| Q3 25 | -1.2% | 6.7% | ||
| Q2 25 | 5.1% | 7.5% | ||
| Q1 25 | 4.3% | 6.4% | ||
| Q4 24 | 5.9% | 13.0% | ||
| Q3 24 | -2.1% | 13.8% | ||
| Q2 24 | -4.1% | 8.0% | ||
| Q1 24 | 1.1% | 4.0% |
每股收益(稀释后)
ASTE
RVTY
| Q4 25 | $0.52 | $0.86 | ||
| Q3 25 | $-0.18 | $0.40 | ||
| Q2 25 | $0.72 | $0.46 | ||
| Q1 25 | $0.62 | $0.35 | ||
| Q4 24 | $0.92 | $0.77 | ||
| Q3 24 | $-0.27 | $0.77 | ||
| Q2 24 | $-0.61 | $0.45 | ||
| Q1 24 | $0.15 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $74.1M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $681.7M | $7.3B |
| 总资产 | $1.4B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTE
RVTY
| Q4 25 | $74.1M | $919.9M | ||
| Q3 25 | $71.8M | $931.4M | ||
| Q2 25 | $91.6M | $991.8M | ||
| Q1 25 | $95.4M | $1.1B | ||
| Q4 24 | $93.8M | $1.2B | ||
| Q3 24 | $58.9M | $1.2B | ||
| Q2 24 | $68.4M | $2.0B | ||
| Q1 24 | $63.8M | $1.7B |
股东权益
ASTE
RVTY
| Q4 25 | $681.7M | $7.3B | ||
| Q3 25 | $668.9M | $7.4B | ||
| Q2 25 | $674.9M | $7.6B | ||
| Q1 25 | $653.2M | $7.6B | ||
| Q4 24 | $637.8M | $7.7B | ||
| Q3 24 | $631.4M | $7.9B | ||
| Q2 24 | $633.3M | $7.9B | ||
| Q1 24 | $650.3M | $7.8B |
总资产
ASTE
RVTY
| Q4 25 | $1.4B | $12.2B | ||
| Q3 25 | $1.3B | $12.1B | ||
| Q2 25 | $1.1B | $12.4B | ||
| Q1 25 | $1.1B | $12.4B | ||
| Q4 24 | $1.0B | $12.4B | ||
| Q3 24 | $1.1B | $12.8B | ||
| Q2 24 | $1.1B | $13.4B | ||
| Q1 24 | $1.1B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $36.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $7.4M | $161.8M |
| 自由现金流率自由现金流/营收 | 1.8% | 21.0% |
| 资本支出强度资本支出/营收 | 7.2% | 2.6% |
| 现金转化率经营现金流/净利润 | 3.01× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $20.7M | $509.4M |
8季度趋势,按日历期对齐
经营现金流
ASTE
RVTY
| Q4 25 | $36.1M | $182.0M | ||
| Q3 25 | $-8.1M | $138.5M | ||
| Q2 25 | $12.9M | $134.3M | ||
| Q1 25 | $20.5M | $128.2M | ||
| Q4 24 | $36.6M | $174.2M | ||
| Q3 24 | $22.5M | $147.9M | ||
| Q2 24 | $10.9M | $158.6M | ||
| Q1 24 | $-47.0M | $147.6M |
自由现金流
ASTE
RVTY
| Q4 25 | $7.4M | $161.8M | ||
| Q3 25 | $-12.3M | $120.0M | ||
| Q2 25 | $9.0M | $115.5M | ||
| Q1 25 | $16.6M | $112.2M | ||
| Q4 24 | $32.1M | $149.8M | ||
| Q3 24 | $19.9M | $125.6M | ||
| Q2 24 | $3.3M | $136.6M | ||
| Q1 24 | $-52.8M | $129.7M |
自由现金流率
ASTE
RVTY
| Q4 25 | 1.8% | 21.0% | ||
| Q3 25 | -3.5% | 17.2% | ||
| Q2 25 | 2.7% | 16.0% | ||
| Q1 25 | 5.0% | 16.9% | ||
| Q4 24 | 8.9% | 20.5% | ||
| Q3 24 | 6.8% | 18.4% | ||
| Q2 24 | 1.0% | 19.7% | ||
| Q1 24 | -17.1% | 20.0% |
资本支出强度
ASTE
RVTY
| Q4 25 | 7.2% | 2.6% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 1.2% | 2.6% | ||
| Q1 25 | 1.2% | 2.4% | ||
| Q4 24 | 1.3% | 3.4% | ||
| Q3 24 | 0.9% | 3.3% | ||
| Q2 24 | 2.2% | 3.2% | ||
| Q1 24 | 1.9% | 2.7% |
现金转化率
ASTE
RVTY
| Q4 25 | 3.01× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 0.77× | 2.49× | ||
| Q1 25 | 1.43× | 3.03× | ||
| Q4 24 | 1.73× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | -13.82× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTE
| Infrastructure Group | $208.7M | 52% |
| Material Solutions | $105.3M | 26% |
| Parts And Component Sales | $58.3M | 15% |
| Other | $15.3M | 4% |
| Service And Equipment Installation Revenue | $6.9M | 2% |
| Cargo And Freight | $6.1M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |